Accustem Sciences Inc.Accustem Sciences Inc.Accustem Sciences Inc.

Accustem Sciences Inc.

No trades
See on Supercharts
Market capitalization
−0.1537USD
‪−2.05 M‬USD
‪6.16 M‬
Beta (1Y)

About Accustem Sciences Inc.

CEO
Wendy Blosser
Headquarters
New York
Employees (FY)
3
Founded
2020
FIGI
BBG015QPWHT9
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ACUT is 0.2770 USD — it has decreased by 20.86% in the past 24 hours. Watch Accustem Sciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Accustem Sciences Inc. stocks are traded under the ticker ACUT.
ACUT stock has fallen by 20.86% compared to the previous week, the month change is a 0.36% rise, over the last year Accustem Sciences Inc. has showed a 75.49% decrease.
ACUT reached its all-time high on Mar 4, 2022 with the price of 3.0000 USD, and its all-time low was 0.2610 USD and was reached on Apr 27, 2022. View more price dynamics on ACUT chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Accustem Sciences Inc. financials in yearly and quarterly reports right on TradingView.
ACUT net income for the last quarter is ‪−526.60 K‬ USD, while the quarter before that showed ‪−246.04 K‬ USD of net income which accounts for −114.03% change. Track more Accustem Sciences Inc. financial stats to get the full picture.
No, ACUT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 3.00 employees. See our rating of the largest employees — is Accustem Sciences Inc. on this list?
Like other stocks, ACUT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Accustem Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Accustem Sciences Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Accustem Sciences Inc. stock shows the neutral signal. See more of Accustem Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.